The incidence of pemphigus in the southern region of Saudi Arabia.

Int J Dermatol

Department of Internal Medicine, College of Medicine and Medical Sciences, King Khalid University and Asir Central Hospital, Abha, Saudi Arabia.

Published: September 2001

Background: This is the first epidemiologic study of pemphigus in the southern region of Saudi Arabia.

Methods: Data were collected from patient records in the outpatient and inpatient departments of Asir Central Hospital during the period 1990-99. The diagnosis of pemphigus was based on the clinical, histopathologic, and direct immunofluorescence patterns which were consistent with pemphigus.

Results: The results showed that the mean incidence of the disease in the general population was 0.16/100 000; the mean incidence of the disease in the population above 20 years of age was 0.27/100 000. The prevalence of the disease at the end of the study period was 1.56/100 000 for the total population, and 2.7/100 000 for the population above 20 years of age. The male to female ratio was 2.2 : 1. The age of onset of the disease ranged from 23 to 67 years, except for one case at an age of 9 years, giving an average of 43.1 +/- 13.4 years and a median of 40 years. Pemphigus vulgaris was the most commonly encountered type, followed by pemphigus erythematosus (94.7% and 5.3%, respectively). Mucosal involvement occurred in 84.2% of cases. No association with neoplasia was found in the current study.

Conclusions: Pemphigus in the southern region of Saudi Arabia is as common as in other parts of the world, but with higher mucosal involvement.

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-4362.2001.01247.xDOI Listing

Publication Analysis

Top Keywords

pemphigus southern
12
southern region
12
region saudi
12
saudi arabia
8
incidence disease
8
population years
8
years age
8
mucosal involvement
8
years
6
pemphigus
5

Similar Publications

A systematic review of paraneoplastic pemphigus and paraneoplastic autoimmune multiorgan syndrome: Clinical features and prognostic factors.

J Am Acad Dermatol

February 2025

Department of Dermatology and Venereology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Electronic address:

Article Synopsis
  • Paraneoplastic pemphigus (PNP), also referred to as paraneoplastic autoimmune multiorgan syndrome (PAMS), is a rare and serious autoimmune condition affecting the skin, mucous membranes, and various organs, with a high risk of mortality.
  • Researchers conducted a comprehensive analysis of 290 articles, including data from 504 patients, to gather insights on demographics, symptoms, associated tumors, treatment options, and survival outcomes.
  • Key findings indicated that older age, specific autoantibodies, and non-Hodgkin lymphoma were linked to shorter survival, while initial oral mucosal involvement and certain skin conditions were associated with longer survival; the study highlighted significant prognostic factors for PNP/PAMS patients.
View Article and Find Full Text PDF
Article Synopsis
  • Pemphigus is a serious skin disease where the body's immune system mistakenly attacks certain proteins, causing blisters.
  • A protein called TWEAK seems to make skin cells die and disrupt connections between them, which could worsen the disease.
  • Researchers found that a substance called naloxone could help protect skin cells from dying and restore the important proteins needed for healthy skin in a lab study and a mouse model of the disease.
View Article and Find Full Text PDF
Article Synopsis
  • Pemphigus foliaceus (PF) is a mild form of pemphigus that shares treatment options with pemphigus vulgaris, commonly involving glucocorticosteroids and immunosuppressants, which can have significant side effects.
  • A case study reported a 54-year-old woman with PF who was treated successfully with apremilast instead of systemic glucocorticosteroids or immunosuppressive agents, as she had previously seen no improvement with a topical steroid.
  • The patient showed improvement with apremilast, maintaining treatment for 9 months without experiencing any side effects, indicating a potential alternative for patients unable or unwilling to use traditional treatments.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!